Form 4: Ares Management CEO Michael Arougheti Executes Stock Sales Under 10b5-1 Trading Plan

Sentiment:

SEC Form 4


Ares Management Corp's CEO, Michael J Arougheti, sold shares of Class A Common Stock between March 20 and March 22, 2024, under a pre-arranged 10b5-1 trading plan.

Summary

  • Michael J Arougheti, Co-Founder, CEO and President of Ares Management Corp, sold shares of Class A Common Stock between March 20 and March 22, 2024.
  • The sales were executed under a 10b5-1 trading plan adopted on December 14, 2023.
  • The transactions involved both direct and indirect holdings through Atticus Enterprises LLC.
  • The prices per share varied across the transactions, ranging from $131.10 to $137.81.
  • Arougheti also holds 1,375,000 restricted units, each representing the right to receive one share of Class A Common Stock upon vesting.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock sales by an executive. It doesn't inherently convey positive or negative sentiment about the company's performance.

Future Outlook

The document does not contain any specific forward-looking statements regarding the company's future performance.

Industry Context

This filing is a routine disclosure of insider trading activity. It's common for executives to use 10b5-1 plans to sell shares over time to avoid accusations of trading on inside information. The market will likely interpret this as a neutral event unless the volume of sales is unusually high or coincides with other negative news.

Comparison to Industry Standards

  • Comparing Arougheti's trading activity to other CEOs in the asset management industry, the use of a 10b5-1 plan is a standard practice.
  • Similar filings can be observed for executives at companies like Blackstone (BX), Apollo Global Management (APO), and KKR & Co (KKR).
  • The scale of the transactions appears to be within a normal range for executives managing personal liquidity and diversification.

Stakeholder Impact

  • The stock sales could have a minor impact on shareholders due to the increased supply of shares in the market.
  • However, the use of a 10b5-1 plan suggests that the sales are not based on any inside information, mitigating potential concerns.

Key Dates

DateDescription
2023-12-14Adoption date of the 10b5-1 trading plan.
2024-03-20Date of the earliest stock sale transaction.
2024-03-21Date of stock sale transactions.
2024-03-22Date of the latest stock sale transaction and filing date of the Form 4.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.